TechMediaBreaks – GivBux Inc. (GBUX) Signs LOI for $39 Million Acquisition of VitorganAmerica.shop
GivBux (OTC: GBUX), a Super App and charitable giving platform, has signed a Letter of Intent to acquire VitorganAmerica.shop, a distributor of biomolecular health products, for $39 million. The acquisition aims to integrate Vitorgan’s regenerative supplements into GivBux’s expanding distribution network across the U.S. and Latin America. Led by Dr. David Contreras, VitorganAmerica.shop produces FDA-registered biomolecular therapies designed for cellular regeneration. GivBux President Umesh Tim Singh stated the deal strengthens the company’s product portfolio and direct-to-consumer reach. The acquisition’s terms will be finalized in a forthcoming Definitive Agreement. To view the full press release, visit https://ibn.fm/g2lxz About GivBux Inc. The GivBux…